03:33 PM EST - Transition Therapeutics Inc. : Received written notification from the NASDAQ Stock Market on May 31, advising the Company that because the bid price of the Company's common shares for the previous 30 consecutive trading days had closed below the minimum $1.00 per share required for continued listing on the NASDAQ Global Market, the Company is not in compliance with NASDAQ Listing Rules. Transition Therapeutics Inc.
shares T.TTH are trading unchanged at $1.09.
